FDA's Woodcock details national security risks of global supply chains
FDA’s Janet Woodcock testifies to Congress about the potential risks to US national security of the pharmaceutical industry’s reliance on Chinese imports.
Archives for November 7, 2019
The next act: ACRO, R&D Caucus moving forward with second Cures bill
ACRO is collaborating with the Congressional Research and Development Caucus and others to bring forth a new Cures bill focused, in part, on patient engagement, data, and digital health – with draft legislation anticipated early next year.